V.A. Cure project is an EU funded H2020 MSCA-ITN Network aiming to uncover core mechanisms of initiation and maintenance of Vascular Anomalies (VAs) and to leverage this information for establishing novel therapeutic strategies.
V.A. Cure project aims to educate and train fourteen Early Stage Researchers by the top experts in the field of vascular anomalies from academic and private sector.
Project's Early Stage Researchers are part of the unique international PhD program, consisting of an individual research project, the network’s training programme, intersectoral secondments and outreach activities.
Project goal is to ensure a comprehensive perception of the research and drug/technology development in pharma/biotech industry and academia.
V.A Cure project is built on collaboration of 7 academic laboratories, 2 companies and 9 partner organisations based in Europe.
Company Details
- Founded
- -
- Industry
- Research
- Website
- http://vacure.eu/
V.a.cure Project Questions
V.A.Cure Project's website is http://vacure.eu/
V.A.Cure Project's LinkedIn profile is https://www.linkedin.com/company/v-a-cure-project
V.A.Cure Project's industry is
Research
V.A.Cure Project's top competitors are
Slush,
Maxiwood Marie Cure Individual Fellowship Project,
Cure Blindness Project,
Suomen Kulttuurirahasto / Finnish Cultural Foundation,
Start Global,
Vascern, European Reference Network On Rare Multisystemic Vascular Diseases,
The Yakes Vascular Malformation Center.
V.A.Cure Project's categories are Research
V.A.Cure Project's founding year is 2019
